Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.

  • Weintraub Z
  • Solovechick M
  • Reichman B
 et al. 
  • 27


    Mendeley users who have this article in their library.
  • 41


    Citations of this article.


AIM: To examine the relation between grade III-IV periventricular/intraventricular haemorrhage (PVH/IVH) and antenatal exposure to tocolytic treatment in very low birthweight (VLBW) premature infants.

STUDY DESIGN: The study population consisted of 2794 infants from the Israel National VLBW Infant Database, of gestational age 24-32 weeks, who had a cranial ultrasound examination during the first 28 days of life. Infants of mothers with pregnancy induced hypertension or those exposed to more than one tocolytic drug were excluded. Of the 2794 infants, 2013 (72%) had not been exposed to tocolysis and 781 (28%) had been exposed to a single tocolytic agent. To evaluate the effect of tocolysis and confounding variables on grade III-IV PVH/IVH, the chi(2) test, univariate analysis, and a logistic regression model were used.

RESULTS: Of the 781 infants (28%) exposed to tocolysis, 341 (12.2%) were exposed to magnesium sulphate, 263 (9.4%) to ritodrine, and 177 (6.3%) to indomethacin. The overall incidence of grade III-IV PVH/IVH was 13.4%. In the multivariate logistic regression analysis, the following factors were related significantly and independently to grade III-IV PVH/IVH: no prenatal steroid treatment, low gestational age, one minute Apgar score 0-3, respiratory distress syndrome, patent ductus arteriosus, mechanical ventilation, and pneumothorax. Infants exposed to ritodrine tocolysis (but not to the other tocolytic drugs) were at significantly lower risk of grade III-IV PVH/IVH after adjustment for other variables (odds ratio = 0.3; 95% confidence interval 0.2 to 0.6).

CONCLUSION: This study suggests that antenatal exposure of VLBW infants to ritodrine tocolysis, in contrast with tocolysis induced by magnesium sulphate or indomethacin, was associated with a lower incidence of grade III-IV PVH/IVH.

Author-supplied keywords

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents: therapeutic use
  • Apgar Score
  • Ductus Arteriosus, Patent
  • Ductus Arteriosus, Patent: complications
  • Female
  • Gestational Age
  • Humans
  • Indomethacin
  • Indomethacin: adverse effects
  • Infant, Newborn
  • Infant, Very Low Birth Weight
  • Intracranial Hemorrhages
  • Intracranial Hemorrhages: chemically induced
  • Logistic Models
  • Magnesium Sulfate
  • Magnesium Sulfate: adverse effects
  • Multivariate Analysis
  • Pneumothorax
  • Pneumothorax: complications
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn
  • Respiratory Distress Syndrome, Newborn: complicati
  • Risk Factors
  • Ritodrine
  • Ritodrine: adverse effects
  • Steroids
  • Tocolytic Agents
  • Tocolytic Agents: adverse effects

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Z Weintraub

  • M Solovechick

  • B Reichman

  • A Rotschild

  • D Waisman

  • O Davkin

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free